APA (7th ed.) Citation

Silverberg, J. I., Simpson, E. L., Farooqui, S. A., Chan, G., Biswas, P., & Güler, E. (2026). Efficacy and Safety of Variable-Dose Versus Continuous-Dose Abrocitinib Treatment in Patients with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis. Dermatology & Therapy, 1. https://doi.org/10.1007/s13555-026-01778-y

Chicago Style (17th ed.) Citation

Silverberg, Jonathan I., Eric L. Simpson, Saleem A. Farooqui, Gary Chan, Pinaki Biswas, and Erman Güler. "Efficacy and Safety of Variable-Dose Versus Continuous-Dose Abrocitinib Treatment in Patients with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis." Dermatology & Therapy 2026: 1. https://doi.org/10.1007/s13555-026-01778-y.

MLA (9th ed.) Citation

Silverberg, Jonathan I., et al. "Efficacy and Safety of Variable-Dose Versus Continuous-Dose Abrocitinib Treatment in Patients with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis." Dermatology & Therapy, 2026, p. 1, https://doi.org/10.1007/s13555-026-01778-y.